Mcam.mnhn.fr

Didier BUISSON
Molécules de Communication et Adaptation tél. : 01 40 79 81 24 / fax. : 01 40 79 31 35 1. PUBLICATIONS

P1- D.Buisson, R.Azerad, G.Revial and J.d'Angelo, "Stereoselective synthesis of
(1R,3S)-cis -chrysanthemic acid through microbiological reduction of 2,2,5,5-
tetramethyl-1,4-cyclohexadione", Tetrahedron Lett. , 25 (1984) 6005-6006.

P2- J.d'Angelo, G.Revial, R.Azerad, D.Buisson, "A short, efficient, highly selective
synthesis of (1R,3S)-cis-chrysanthemic acid through microbiological reduction of
2,2,5,5-tetramethyl-1,4-cyclohexadione", J.Org.Chem., 51 (1986) 40-45.

P3- D.Buisson and R.Azerad, "Diastereoselective and enantioselective microbial
reduction of cyclic alpha-alkyl beta-ketoesters " Tetrahedron Lett., 27 (1986) 2631-
2634.

P4- D.Buisson, S.el Baba and R.Azerad, " Yeast-catalysed asymetric reduction of benzil
and benzoin to hydroxybenzoin" Tetrahedron Lett., 27 (1986) 4453-4454.

P5- J.Ouazzani-Chahdi, D.Buisson and R.Azerad, "Preparation of both enantiomers of a
chiral lactone through combined microbiological reduction and oxidation",
Tetrahedron Lett. , 28 (1987) 1109-1112.

P6- D.Buisson,
enantioselective microbiological reduction of 2-methyl 3-oxoalkanoates",
Tetrahedron Lett., 28 (1987) 3939-3940.

P7- D.Buisson, S.Henrot, M.Larchevêque and R.Azerad, "New chiral building blocks by
microbial asymmetric reduction: a direct access to functionalized 2R,3R- and 2S,3R-
2-methyl-3-hydroxy butyrate synthons", Tetrahedron Lett., 28 (1987) 5033-5036.

P8- F.Trigalo, D.Buisson and R.Azerad, "Chemoenzymatic synthesis of conformationally
rigid glutamic acid analogues", Tetrahedron Lett., 29 (1988) 6109-6112.

P9- J.Gillois, D.Buisson, R.Azerad and G.Jaouen, "Enantioselective microbial reduction
of transition-metal-complexed aromatic ketones", J.Chem.Soc.Chem.Comm., (1988) 1224-1225.
P10- M.Larchevêque, C.Sanner, R.Azerad and D.Buisson, "The use of methyl substituted
chiral synthons in the synthesis of pine sawflies pheromones", Tetrahedron , 44
(1988) 6407-6418.
P11- J.Gillois, D.Buisson, R.Azerad and G.Jaouen, "Synthèse asymétrique d'alcools
benchrotréniques par voie microbiologique", J.Organometal.Chem., 367 (1989) 85-
93.

P12- D.Buisson, R.Azerad, C.Sanner and M.Larchevêque, "Stereocontrolled reduction of
alpha-methyl beta-ketoesters by Geotrichum candidum", Biocatalysis , 3 (1990) 85-
93.

P13- D.Buisson, R.Azerad, C.Sanner and M.Larchevêque, "Stereocontrolled reduction of
β−ketoesters by Geotrichum candidum. Preparation of D-3-hydroxyalkanoates",
Tetrahedron : Asymmetry, 2(1991) 987-988.

P14- D.Buisson, C.Sanner, M.Larchevêque and R.Azerad, "A study of the
stereocontrolled reduction of aliphatic β−ketoesters by Geotrichum candidum", Biocatalysis , (1992), 249-265
P15- M.Ismaili-Alaoui, B.Benjilali, D.Buisson et R.Azerad, "Biotransformation of
Terpenic Compounds by Fungi I. Metabolism of R-(+)-Pulegone", Tetrahedron Lett.,
(1992), 33, 2349-2352

P16
- O.Cabon, M.Larchevêque, D.Buisson and R.Azerad, "Microbial reduction of 2-
chloro-3-aryl-oxo-propionic acid esters", Tetrahedron Lett., (1992), 33, 7377-7340

P17- D.Buisson, R.Cecchi, J.-A.Laffitte, U.Guzzi and R.Azerad, "Microbial reduction of
1-tetralone 2-carboxyesters as a source of new asymmetric synthons" Tetrahedron
Lett.
, (1994), 35,3091.

P18- Lacroix, I.; Buisson, D.; Philippe, M.; Azerad, R., "4-hydroxy-2-(N-
indolinyl)butane, a new metabolite of indoline in fungi", Nat.Prod.Lett. , (1995), 7,
15-22.

P19- Cabon, O.; Buisson, D.; Larchevêque, M.; Azerad, R., "Microbial reduction of 2-
chloro-3-oxoesters", Tetrahedron : Asymmetry , (1995), 6(9), 2199-2210.

P20- Cabon, O.; Buisson, D.; Larchevêque, M.; Azerad, R., "Stereospecific Preparation of
Glycidic Esters from 2-Chloro-3-Hydroxyesters. Application to the Synthesis of
(2R,3S)-3-Phenylisoserine", Tetrahedron : Asymmetry , (1995), 6(9), 2211-2218.

P21- Mehmandoust, M.; Buisson, D.; Azerad, R., "Microbial reduction of 2-cyano-1-
Tetralones", Tetrahedron Lett. , (1995), 36(36), 6461-6462.

P22- Buisson, D.; Azerad, R., "A chemoenzymatic preparation of both enantiomers of ω-
hydroxymethyl-substituted lactones", Tetrahedron : Asymmetry , (1996), 7, 9-12.

P23- C. Abalain, D. Buisson and R. Azerad, "Selective synthesis of carbomethoxy 2-
tetralols stereoisomers by microbial reduction of corresponding tetralones",
Tetrahedron: Asymmetry , (1996), 7(10), 2983-2996.
P24- F. Trigalo, D. Buisson and R. Azerad, "Enantioselective reduction of carbon-carbon
double bond : Preparation of isopropyl (S)-3-oxocyclopentanecarboxylate by
reduction of isopropyl 3-oxocyclopentene carboxylate using Geotrichum candidum",
Prep. Biotrans, (1996), 2:7.8

P25- J. Cossy, A. Schmitt, C. Cinquin D. Buisson and D. Belotti, "A very short, efficient
and inexpensive synthesis of the prodrug form of SC-54701A a platelet aggregation
inhibitor", Bioorg. Med. Chem. Lett. , (1997), 7, 1699-1700.

P26- S. Danchet, C. Bigot, D. Buisson and R. Azerad, "Dynamic kinetic resolution in the
microbial reduction of α-monosubstituted β-oxoesters : the reduction of 2-
carbethoxy-cycloheptanone and 2-carbethoxy-cyclooctanone", Tetrahedron :
Asymmetry
, (1997), 8, 1735-1739.

P27- S. Danchet, D. Buisson and R. Azerad, "Microbial reduction of varying size cyclic
β-ketoesters. Stereoselective synthesis of chiral lactones and epoxydes.", J. Mol. Cat.
B : Enz.
, (1998), 5, 255-259.
P28- D. Buisson and R. Azerad, "On the preparation and use of (S)-O-acetyl-lactyl
chloride as a derivatizing chiral auxiliary", Tetrahedron : Asymmetry , (1999), 10,
2997-3002.

P29- D. Buisson, X. Baucherel, E. Levoirier and S. Jugé,"Baker's yeast reduction of α-
hydroxy α-alkyl β-ketoesters", Tetrahedron Letters, (2000), 41, 1389-1392.

P30- L.Veum, H.Brouard, P.Meffre, M.Larchevêque, D.Buisson, E.Demousseau and
R.Azerad, "Chemoenzymatic synthesis of enantiopure 1,1'-disubstitued ferrocenyl
aminoalcohols",Tetrahedron Asymmetry , (2000), 11, 4055-4059.

P31- L. Fonteneau, S. Rosa and D. Buisson, " Chemoenzymatic synthesis of enantiopur
isopropyl (3R)-and (3S)-3-hydroxycyclohex-1-ene-1-carboxylates and their reduction
toisomers of isopropyl 3-hydroxy-cyclohexane-1-carboxylate" Tetrahedron
Asymmetry
(2002), 13, 579-585.
C. Mazier, M. Jaouen, M-A. Sari and D. Buisson, "Microbial Oxidation of
Terfenadine and Ebastine Into Fexofenadine and Carebastine "Bioorganic and
Medicinal Chemistry Letters,
(2004) 14(21) 5423-5426

P33- P. Lafite, S. Dijols, D. Buisson, A.C. Macherey, D. Zeldin, P. Dansette and D.
Mansuy. "Design and synthesis of selective, high-affinity inhibitore of human
cytochrome P450 2J2" Bioorganic and Medicinal Chemistry Letters, (2006) 16 2777-
2780.
C. Mazier, M. Lombard, M-A. Sari and D. Buisson, "Oxidation of terfenadine by
Streptomyces platensis. Influence of culture medium on metabolites formation"
Biocatalysis and Biotransformation, (2007) 25(5): 401 - 407.
Buisson, D., J. Quintin, et al. "Biotransformation of polymethoxylated flavonoids:
Access to their 4 '-O-demethylated metabolites." J Nat Prod (2007) 70(6): 1035-
1038.
P36 Padhi, S. K., I. A. Kaluzna, et al. (2007). "Reductions of cyclic [beta]-keto esters by
individual Saccharomyces cerevisiae dehydrogenases and a chemo-enzymatic route
to (1R,2S)-2-methyl-1-cyclohexanol." Tetrahedron: Asymmetry 18(18): 2133.
El Ouarradi, A., I. Salar-Arnaud, et al. (2008). "Biooxidation of methyl group:
Application to the preparation of alcohol and acid metabolites of terfenadine, ebastine and
analogues." Tetrahedron 64: 11738-11744.

P38 El Quintin, J., D. Buisson, et al. (2009). "Semisynthesis and antiproliferative
evaluation of a series of 3 '-aminoflavones." Bioorganic & Medicinal Chemistry
Letters 19(13): 3502-3506.

R1-
R.Azerad and D.Buisson, "Dynamic resolution and stereoinversion of secondary
alcohols by chemo-enzymatic processes", Current Opinion in Biotechnology, (2000),
11, 565-571.

R2- D. Buisson, "Asymmetric syntheses of hydroxylactones and epoxyesters via
microbiological biotransformation of carbonyl compounds", Trends in Heterocyclic Chemistry, Vol.7,(2001), 163-167.
3. COMMUNICATIONS PUBLIEES
C1-
F.Trigalo, D.Buisson, F.Acher and R.Azerad, "Synthesis and use of conformationally
strained glutamic acid analogues", in Colloques Inserm: 2nd Forum on Peptides, A.Aubry, M.Marraud and B.Vioux. ed., vol.174, J.Libbey Eurotext Ltd, 1989, pp. 297-300
C2- R.Azerad, D.Buisson, S.Maillot et J.Ouazzani-Chahdi, "The microbiological
reduction/oxidation concept: an approach to a chemoenzymatic preparation of optically pure lactones and lactonic synthons", in."Bioorganic Chemistry in Health-care and Technology" (U.Pandit et A.Alderweiter ed.), NATO Symposium Series, vol.207.(1991) pp. 233-236.
C3- R.Azerad and D.Buisson, "Stereocontrolled reduction of β−ketoesters with
Geotrichum candidum", in "Microbial Reagents in Organic Synthesis", S.Servi ed., Kluwer,Dordrech (1992), pp.421-440.
C4- M.Ismaili-Alaoui, B.Benjilali, D.Buisson and R.Azerad, " Microbiological oxidation
of 1,8-cineole", in Rivista Italiana EPPOS, (1993),756-9.
C5- M.Ismaili-Alaoui, B.Benjilali, D.Buisson and R.Azerad, "Role of bioconversions in
processing of natural substances : case of essential oil", in Rivista Italiana EPPOS, (1997), 489-504.
4. BREVETS
B1- Nouveaux tetra-alkyl-2,2,5,5 cyclohexanone-4 ol-1 et leurs dérivés sulfonés, leurs
procédés et leurs intermédiaires de préparation et leur application à la synthèse de lactones cyclopropanique cis.EP 0 122 202 A2, d'Angelo,J.; Revial,G.; Azerad,R.; Buisson,D.; 1984.
B2- 1-Hydroxy-2-alkoxycarbonyl-tétralines optiquement pures, procédé pour leur
préparation et leur utilisation comme intermédiaires clés de synthèse", ELF SANOFI, FR 93 00529, 1993,.R.Azerad, D.Buisson, R.Cecchi, U.Guzzi, J.-A.Laffitte.

Source: http://mcam.mnhn.fr/images/pubs_DB.pdf

Landkreis kassel

Gibt es Beispiele aus der Vergangenheit für solch um eine Grippeerkrankung zu vermeiden, die bei eine Bedrohung? Aufenthalt z.B. in Asien oder bei Rückkehr nach Im vergangenen Jahrhundert kam es 1918, 1957 und Europa fälschlich für eine Vogelgrippe gehalten 1968 zu Influenza - Pandemien, die zu vielen Millio-wird und zu seuchenhygienischen Maßnahmen nen Todesopfern führte.

Cases 2009

Case 1 A 12-month-old infant is admitted to the hospital because of dehydration and diarrhea of 3 days' duration. The infant weighed 10 kg at a well visit 1 week ago. She has had 10 to 12 stools per day for the past few days and a temperature of 39°C. She has not urinated for the past 18 hours. Physical examination reveals sunken eyes and dry, tenting skin. Which of the following would you

Copyright © 2018 Medical Abstracts